Fig. 1

Selection process of patients. pN, pathological N stage; NSCLC, non-small-cell lung cancer; KPS, Karnofsky performance status; TKI, tyrosine kinase inhibitors; EGFRwt, EGFR wild-type; EGFRm, EGFR-mutated; PORT, postoperative radiotherapy